Posterior Corpectomy in Thoracolumbar Spinal Metastatsis

Status Not yet recruiting

Clinical Trial Summary

To analyze the short-term outcomes of posterior corpectomy of patients with thoracolumbar spinal metastasis in spine unit in Assiut University hospital regarding the pain control , neurological status , complication and ambulatory status as well as mortality rate.

Clinical Trial Description

The metastasis is the spread of cancer from one part of the body to another. Two-thirds of patients with cancer will develop bone metastases. Breast, prostate and lung cancer are responsible for more than 80% of cases of metastatic bone disease. A spinal metastasis may cause pain, instability and neurological injuries. - The spine is the most common site of bone metastasis . It is estimated that over the 10% of patients with cancer will develop a symptomatic spinal metastasis . Algra et al. suggest that the initial anatomic location of metastases within vertebrae is in the posterior portion of the body. - Spinal metastases are the most common tumors of the spine, comprising approximately 90% of masses encountered with spinal imaging. Within the spinal column, metastasis is more commonly found in the thoracic region, followed by the lumbar region, while the cervical region is the least likely place professionals find metastasis . - Spinal metastases most commonly affect the vertebral bodies of the spinal column, and spinal cord compression is an indication for surgery. Commonly, an open posterior approach is employed to perform a transpedicular, costotransversectomy or lateral extracavitary corpectomy. Because of the short life expectancies in patients with metastatic spinal disease, decreasing the morbidity of surgical treatment and recovery time is critical. - At present, both surgical and nonsurgical treatments are used for the treatment of spinal tumors, however, treatment outcome is dependent on various factors, such as patient age, overall health of the patient . - When treating patients with vertebral metastases, surgical strategy is mainly based on life expectancy, primary site of tumor, and staging. This helps determine which patients will benefit from surgery and the type of procedure. Tokuhashi developed a score to determine life expectancy in order to facilitate the treatment modality decision . - Vertebral corpectomy refers to the removal of one or more vertebral bodies from the spine, as well as the intervertebral discs above and below the surgical level. Corpectomies may be accomplished through a multitude of approaches. Posterior approaches have been associated with less intraop- erative blood loss, complications, shorter operative time, and better pul- monary function post-operation compared to anterior approaches . ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06117475
Study type	Observational
Source	Assiut University
Contact	Rehab Ma Ahmed, Resident
Phone	01025345048
Email	rehabmahmoud@med.aun.edu.eg
Status	Not yet recruiting
Phase
Start date	November 1, 2023
Completion date	December 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05023772` - Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases	N/A
Suspended	`NCT04115254` - Stereotactic Magnetic Resonance Guided Radiation Therapy	N/A
Recruiting	`NCT04375891` - Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation	N/A
Recruiting	`NCT04802603` - Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column	N/A
Not yet recruiting	`NCT04635137` - Ablation and Cementoplasty for Painful Bone Lesions	N/A
Recruiting	`NCT03963713` - Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic Tumors	N/A
Active, not recruiting	`NCT04227717` - Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine
Recruiting	`NCT04218617` - Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases	Phase 2
Completed	`NCT02367378` - Minimally Invasive Surgery (MIS) for Spine Metastases	N/A
Recruiting	`NCT06165419` - Definitive Radiation for High-Risk Spine Metastases	Phase 2
Recruiting	`NCT05534321` - Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease	Phase 1/Phase 2
Recruiting	`NCT05495399` - Post Operative RT for Limited Spine Metastases	N/A
Recruiting	`NCT05317026` - Increased Early Pain Relief by Adding Vertebroplasty to SBRT	N/A
Terminated	`NCT02174107` - Health Economics Evaluation of Percutaneous Vertebroplasty Compared to Radiation Therapy in Patients With Painful Spine Metastases.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.